- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07913997
Cognitive-Motor Training With the DextEgg in Children With ADHD (ADHD DextEgg)
Investigating the Relationship Between Fine Motor Skills and Cognitive-Motor Training in Children With ADHD: a Randomized Controlled Trial
Attention Deficit Hyperactivity Disorder (ADHD) is frequently accompanied by deficits in executive functions and fine motor skills, which affect daily activities, academic performance, and health-related quality of life. The DextEgg is a gamified hand-training device with motion and pressure sensors that connects to a tablet app and allows fine motor exercises to be combined with cognitive demands (inhibition, working memory, cognitive flexibility). This single-center randomized controlled trial evaluates whether a 4-week home-based cognitive-motor training with the DextEgg improves fine motor skills and executive functions in children aged 8 to 12 years with ADHD, compared with a motor-only DextEgg training of identical dose. Fifty children will be randomized 1:1 and complete 20 home-based sessions (5 per week, 35 minutes each). Assessments take place at baseline, after the intervention, and at 3-month follow-up.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Manuela Pastore-Wapp, PhD
- Telefonnummer: 0412057220
- E-post: manuela.pastore-wapp@unibe.ch
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Age 8 years 0 months to 12 years 11 months
- Clinical ADHD diagnosis according to DSM-5, confirmed by a physician or psychologist
- Written informed consent by legal guardian and assent by the child
- Caregiver-reported difficulties in fine motor tasks (e.g., handwriting, tying shoes)
- Caregiver-reported executive functioning difficulties in daily life
Exclusion Criteria:
- Any other significant neurological, developmental, or psychiatric condition that could affect fine motor or cognitive functioning
- Participation in another intervention study during the study period
- Inability to follow study procedures due to language difficulties or other barriers
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Cognitive-Motor DextEgg Training
20 home-based sessions over 4 weeks (5x/week, 35 min): finger-specific dexterity exercises with embedded cognitive challenges (inhibition, working memory, cognitive flexibility), adaptive difficulty |
Gamified, app-guided home training with the DextEgg (sensor-equipped hand trainer connected via Bluetooth to a tablet) combining fine motor tasks (tapping, squeezing, rolling) with inhibition, working memory and cognitive-flexibility demands. Other names: Smart Sensor Egg (SSE). |
|
Aktiv komparator: Motor-Only DextEgg Training
Same schedule, device and fine motor tasks, but without embedded cognitive challenge |
Identical fine motor sequences with the DextEgg without dual-task or rule-switching elements; controls for device use, motor activity and training time. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Fine motor skills (M-ABC-3 fine motor coordination)
Tidsramme: Baseline, post-intervention (week 5), 3-month follow-up
|
Movement Assessment Battery for Children, 3rd edition, fine motor coordination subscale (placing pegs, threading lace, drawing trail) |
Baseline, post-intervention (week 5), 3-month follow-up
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Functional dexterity
Tidsramme: Baseline, post-intervention (week 5), 3-month follow-up
|
Functional Dexterity Test (FDT) |
Baseline, post-intervention (week 5), 3-month follow-up
|
|
Inhibitory control
Tidsramme: Baseline, post-intervention (week 5), 3-month follow-up
|
D-KEFS Color Word Interference Test, Part III |
Baseline, post-intervention (week 5), 3-month follow-up
|
|
Cognitive flexibility
Tidsramme: Baseline, post-intervention (week 5), 3-month follow-up
|
D-KEFS Color Word Interference Test, Part IV |
Baseline, post-intervention (week 5), 3-month follow-up
|
|
Verbal working memory
Tidsramme: Baseline, post-intervention (week 5), 3-month follow-up
|
WISC-V Digit Span (forward and backward) |
Baseline, post-intervention (week 5), 3-month follow-up
|
|
Visual working memory
Tidsramme: Baseline, post-intervention (week 5), 3-month follow-up
|
WISC-V Picture Span |
Baseline, post-intervention (week 5), 3-month follow-up
|
|
Attention
Tidsramme: Baseline, post-intervention (week 5), 3-month follow-up
|
TAP subtests Go/No-Go and Divided Attention |
Baseline, post-intervention (week 5), 3-month follow-up
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- ADHD DextEgg
- BASEC (Annen identifikator: 2026-00938)
- SNCTP (Annen identifikator: SNCTP000006929)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .